The pronounced Th17 profile in systemic sclerosis (SSc) together with intracellular expression of TGFbeta and IFNgamma distinguishes SSc phenotypes.
about
Challenges and Current Efforts in the Development of Biomarkers for Chronic Inflammatory and Remodeling Conditions of the LungsSpotlight on tocilizumab and its potential in the treatment of systemic sclerosisGene expression profiling offers insights into the role of innate immune signaling in SScSerum protein profiling of systemic lupus erythematosus and systemic sclerosis using recombinant antibody microarraysSOCS3 regulates graft-versus-host disease.High IL-17E and low IL-17C dermal expression identifies a fibrosis-specific motif common to morphea and systemic sclerosis.Elevated levels of CD4(+)CD25(+)FoxP3(+) T cells in systemic sclerosis patients contribute to the secretion of IL-17 and immunosuppression dysfunction.Interleukin 13- and interleukin 17A-induced pulmonary hypertension phenotype due to inhalation of antigen and fine particles from air pollutionCharacterization of HCV-specific CD4+Th17 immunity in recurrent hepatitis C-induced liver allograft fibrosis.Experimentally-derived fibroblast gene signatures identify molecular pathways associated with distinct subsets of systemic sclerosis patients in three independent cohorts.Interleukin-17A promotes functional activation of systemic sclerosis patient-derived dermal vascular smooth muscle cells by extracellular-regulated protein kinases signalling pathway.IL-17A induces endothelial inflammation in systemic sclerosis via the ERK signaling pathwayTLR7, IFNγ, and T-bet: their roles in the development of ABCs in female-biased autoimmunity.Vascular involvement in systemic sclerosis (scleroderma).Tanshinone IIA attenuates interleukin-17A-induced systemic sclerosis patient-derived dermal vascular smooth muscle cell activation via inhibition of the extracellular signal-regulated kinase signaling pathwayPathogenesis of Systemic Sclerosis.Increased frequency of circulating Th22 in addition to Th17 and Th2 lymphocytes in systemic sclerosis: association with interstitial lung disease.The Role of IL-17 and Th17 Lymphocytes in Autoimmune DiseasesIL-21 Promotes Pulmonary Fibrosis through the Induction of Profibrotic CD8+ T Cells.Interleukin-17A and interleukin-23 in morphea.Cytokine profiles in localized scleroderma and relationship to clinical features.Frequency of circulating topoisomerase-I-specific CD4 T cells predicts presence and progression of interstitial lung disease in sclerodermaPhenotypic Alterations Involved in CD8+ Treg Impairment in Systemic SclerosisInterferon-γ and systemic autoimmunity.Th17 cytokines and arthritisTh17 cells favor inflammatory responses while inhibiting type I collagen deposition by dermal fibroblasts: differential effects in healthy and systemic sclerosis fibroblasts.Increased frequency of Th17 cells in systemic sclerosis is related to disease activity and collagen overproduction.Autologous haemopoietic stem cell transplantation for autoimmune diseases.Deciphering the genetic background of systemic sclerosis.Immunotherapeutic implication of IL-6 blockade.Circulating biomarkers of interstitial lung disease in systemic sclerosis.Is CD69 an effective brake to control inflammatory diseases?Transforming growth factor β--at the centre of systemic sclerosis.CD4+ Group 1 Innate Lymphoid Cells (ILC) Form a Functionally Distinct ILC Subset That Is Increased in Systemic Sclerosis.Photopheresis: Advances and Use in Systemic Sclerosis.Aberrant immune response with consequent vascular and connective tissue remodeling - causal to scleroderma and associated syndromes such as Raynaud phenomenon and other fibrosing syndromes?IL-17, IL-6 and IFN-γ in Systemic Sclerosis Patients.CD69: from activation marker to metabolic gatekeeper.Potential roles of interleukin-17A in the development of skin fibrosis in mice.Crucial role for CD69 in allergic inflammatory responses: CD69-Myl9 system in the pathogenesis of airway inflammation.
P2860
Q26766294-FEE7F51B-4C1B-436D-80F4-839B8D8327EAQ28073706-B9A0561C-2EFA-48F2-A2B3-53F6EC573331Q28083733-0DBA962B-2B10-4E0C-8A4F-676FDF6F650EQ33829507-93518C8D-06E7-4119-B207-41BBD11057DDQ34022451-06C35E76-9706-4DD3-9E68-459661452AE7Q34066564-FF2A65FB-B1B4-442C-A7BC-9811422ADA48Q34775608-3973CF99-CEFA-47D8-853F-9847E6A097BAQ34782588-0ED75E8F-B6C9-4FF1-A0B3-FE68F468AA46Q34795394-CCD2C09B-AD0C-459C-A2A7-DEED0B61F4CCQ34995163-E9AE0BD4-ABA1-42B1-8CD5-6D623428D0FBQ35047990-21ED64B8-3024-4D56-AFCB-67E4230F9CFBQ35078513-BB44D72C-8127-4328-94C6-27924C209BB5Q35235610-BF6E9405-2503-40E9-812C-3D6E4C62A6ADQ35557424-1FBB9A79-FF90-493A-AC05-859D89B31A06Q35565348-9B33DCFA-7EE5-4933-B56E-F7BAA44D7C11Q35693212-5C98D516-E4A4-4D1A-A3EC-2E74E0BB0354Q35840797-E89CB663-993A-4DFE-BB3F-3C2CBC90B28BQ36249305-6D088ACE-B0BF-4EE8-B8FE-0CBC56DD59ACQ36304913-1388D7D0-4A2F-4D8A-880B-1DFBC1652E66Q36524875-4BC7D3CA-5535-4283-9256-53D6063AAE44Q36784652-E10D7B8E-F91C-47E0-BDA9-B23D66472ED1Q36871425-F95521D1-5982-4BBD-94C8-BC8C7E052688Q37592670-1EA24879-B458-4FDA-8E5C-F823855FCE5EQ37603372-DF4315A4-9B0D-4B1B-908D-46A69EBB31D2Q37686348-509313B0-7143-4934-A5AB-2A447FAA8D5DQ37691158-E7E665DA-3681-42F0-B67E-E1F8E9C04490Q37691199-EA0892A0-8CC8-42E7-8C2E-8F86BA3E1CF7Q37879139-33F8AF6E-C654-48BE-AFFF-94D7D3946990Q37905783-63873191-155E-47F4-8A50-E706EC238FF7Q37965754-2C75CE4B-600A-46D3-BC99-47B93165C322Q38044387-7C64822B-A4D9-4996-A04D-A27AE4B0DF45Q38129638-E8B5DC37-BA75-498A-BA0D-854C63EFEEEDQ38241227-6A517F9F-E644-41C9-9E73-5111BFCF031BQ38577294-A68B6C0F-9D2E-45BD-8F43-0B469F916A87Q38807643-F173EFFC-9C82-4A75-9314-FFA700EEB4D1Q38829051-8FCD0C52-6294-4D7A-9408-15FB7F8B13D2Q38995396-A379E4B5-0EB8-40F1-8CCA-AB87544A3036Q39285769-F4BE424D-9055-40F4-9B7E-9B3BADDA5492Q39308063-CE6B8D46-E643-422A-9E43-1F906826488EQ39402889-2BD05A3E-1C5B-4454-A25C-ECDFEE790C20
P2860
The pronounced Th17 profile in systemic sclerosis (SSc) together with intracellular expression of TGFbeta and IFNgamma distinguishes SSc phenotypes.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
The pronounced Th17 profile in ...... distinguishes SSc phenotypes.
@ast
The pronounced Th17 profile in ...... distinguishes SSc phenotypes.
@en
type
label
The pronounced Th17 profile in ...... distinguishes SSc phenotypes.
@ast
The pronounced Th17 profile in ...... distinguishes SSc phenotypes.
@en
prefLabel
The pronounced Th17 profile in ...... distinguishes SSc phenotypes.
@ast
The pronounced Th17 profile in ...... distinguishes SSc phenotypes.
@en
P2093
P2860
P1433
P1476
The pronounced Th17 profile in ...... distinguishes SSc phenotypes.
@en
P2093
Anila Hussiani
Dirk M Wuttge
Erik Lubberts
Jasper Broen
Lenny van Bon
Robbert Simms
Roger Hesselstrand
Timothy R D J Radstake
Yanhui Deng
P2860
P356
10.1371/JOURNAL.PONE.0005903
P407
P577
2009-06-17T00:00:00Z